Stock Events

Stock Events

Celldex Therapeutics (CLDX) Q2 2017 Earnings

9MayConfirmed

Aug 16

Q4 2016

Q1 2017

Q2 2017

-5.55

-3.81

-2.06

-0.32

Details

Expected EPS

-4.27

Actual EPS

-3.75

Surprise EPS

0.52

Surprise Percent

+12.18%

Description

Celldex Therapeutics (CLDX) has reported earnings of -3.75 per share for Q2 2017.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.